Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer

Stopped early · Phase 2

Conditions studied: Esophageal Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving chemotherapy drugs and radiation therapy before surgery may shrink the tumor so that it can be removed during surgery. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy given before surgery in treating patients who have stage I, stage II, or stage III esophageal cancer.

Key facts

Study ID

NCT00006472

Run by

Medstar Health Research Institute

People needed

4

Starts

2000-01-01

Expected to finish

2002-09-10

Last updated by the study team

2020-08-18

Who can join

Age: any, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Washington Cancer Institute — Washington D.C., District of Columbia, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Union Memorial Hospital — Baltimore, Maryland, United States
• Harbor Hospital Center — Baltimore, Maryland, United States
• Franklin Square Hospital Center — Baltimore, Maryland, United States
• Good Samaritan Hospital of Maryland — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.